Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy. Results of their study were published in the Journal for Immunotherapy of Cancer.
TIL therapy starts with doctor’s removing tumors from the patient. These tumors are sent to a lab, where they are dissected to collect immune cells that have…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply